Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Whitehawk Therapeutics (WHWK) Debt to Equity (2021)

Historic Debt to Equity for Whitehawk Therapeutics (WHWK) over the last 1 years, with Q4 2021 value amounting to $0.04.

  • Whitehawk Therapeutics' Debt to Equity changed N/A to $0.04 in Q4 2021 from the same period last year, while for Dec 2021 it was $0.04, marking a year-over-year change of. This contributed to the annual value of $0.04 for FY2021, which is N/A changed from last year.
  • Whitehawk Therapeutics' Debt to Equity amounted to $0.04 in Q4 2021.
  • Whitehawk Therapeutics' 5-year Debt to Equity high stood at $0.04 for Q4 2021, and its period low was $0.04 during Q3 2021.